Inventor
TOMOYA MIYAKAWA
Inventor
JP
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
C12NMicroorganisms or enzymes18%
PatentTitleYear
12,448,413HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell202511,759,518Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein202311,618,770MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same202311,491,204Composition comprising poly I:C and LAG-3-IGG fusion protein202211,304,997HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell202211,291,718Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to CYTLIMIC INC (3)· patent assignee history
2022–2025Based in JP· patent location history
2023–2025Patents assigned to NEC CORP (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CYTLIMIC INC | 3 | 2022 |
| NEC CORP | 3 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 6 | 2022–2025 |